The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study

SIMPLE SUMMARY: The liver is a common metastatic site of non-small cell lung cancer (NSCLC) and is associated with a poor prognosis. Immune checkpoint inhibitors (ICIs), represented by programmed death-1 (PD-1)/ programmed death ligand-1 (PD-L1) inhibitors, have significantly improved efficacy in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Mingying, Li, Na, Xu, Xiaoling, Xu, Yanjun, Li, Hui, Zhu, Liang, Sheng, Jiamin, Zhou, Zichao, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454794/
https://www.ncbi.nlm.nih.gov/pubmed/36077868
http://dx.doi.org/10.3390/cancers14174333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454794/
https://www.ncbi.nlm.nih.gov/pubmed/36077868
http://dx.doi.org/10.3390/cancers14174333

Ejemplares similares